CORE LABORATORIES N V Quarterly Income Tax Expense (Benefit) in USD from Q1 2010 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Core Laboratories N V quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2010 to Q1 2023.
  • Core Laboratories N V Income Tax Expense (Benefit) for the quarter ending March 31, 2023 was $610K.
  • Core Laboratories N V Income Tax Expense (Benefit) for the twelve months ending March 31, 2023 was $12.1M, a 4.28% decline year-over-year.
  • Core Laboratories N V annual Income Tax Expense (Benefit) for 2022 was $10.3M, a 35.2% decline from 2021.
  • Core Laboratories N V annual Income Tax Expense (Benefit) for 2021 was $15.9M, a 170% increase from 2020.
  • Core Laboratories N V annual Income Tax Expense (Benefit) for 2020 was $5.9M.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $12.1M $610K +$1.81M Jan 1, 2023 Mar 31, 2023 10-Q 2023-04-27
Q4 2022 $10.3M $5.85M -$2.98M -33.7% Oct 1, 2022 Dec 31, 2022 10-K 2023-02-10
Q3 2022 $13.3M $3.86M +$894K +30.2% Jul 1, 2022 Sep 30, 2022 10-Q 2022-10-28
Q2 2022 $12.4M $1.79M -$264K -12.9% Apr 1, 2022 Jun 30, 2022 10-Q 2022-07-28
Q1 2022 $12.6M -$1.2M -$3.25M -158% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-27
Q4 2021 $15.9M $8.82M +$2.28M +34.9% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-10
Q3 2021 $13.6M $2.96M -$701K -19.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-28
Q2 2021 $14.3M $2.05M +$2.31M Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-28
Q1 2021 $12M $2.05M +$6.1M Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-28
Q4 2020 $5.9M $6.54M -$637K -8.88% Oct 1, 2020 Dec 31, 2020 10-K 2021-02-08
Q3 2020 $6.53M $3.66M +$328K +9.84% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-29
Q2 2020 $6.21M -$261K -$5.07M -105% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-30
Q1 2020 $11.3M -$4.05M +$23.6M +85.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-23
Q4 2019 -$12.3M $7.18M +$1.43M +24.8% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-08
Q3 2019 -$13.7M $3.34M -$6.07M -64.5% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-08
Q2 2019 -$7.65M $4.81M -$212K -4.22% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-08
Q1 2019 -$7.44M -$27.6M -$32.9M -624% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-08
Q4 2018 $25.4M $5.75M -$2.27M -28.3% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-10
Q3 2018 $27.7M $9.4M +$5.81M +162% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-10
Q2 2018 $21.9M $5.02M +$1.31M +35.3% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-10
Q1 2018 $20.6M $5.27M +$2.34M +80% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-10
Q4 2017 $18.2M $8.02M +$4.41M +122% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-11
Q3 2017 $13.8M $3.6M +$1.51M +72.8% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-11
Q2 2017 $12.3M $3.71M +$3.04M +453% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-11
Q1 2017 $9.29M $2.93M -$1.46M -33.3% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-11
Q4 2016 $10.7M $3.61M -$1.05M -22.6% Oct 1, 2016 Dec 31, 2016 10-K 2018-02-12
Q3 2016 $11.8M $2.08M -$7.67M -78.7% Jul 1, 2016 Sep 30, 2016 10-K 2018-02-12
Q2 2016 $19.5M $671K -$9.4M -93.3% Apr 1, 2016 Jun 30, 2016 10-K 2018-02-12
Q1 2016 $28.9M $4.39M -$4.88M -52.7% Jan 1, 2016 Mar 31, 2016 10-K 2018-02-12
Q4 2015 $33.8M $4.66M -$16.2M -77.7% Oct 1, 2015 Dec 31, 2015 10-K 2017-02-10
Q3 2015 $49.9M $9.75M -$10.2M -51% Jul 1, 2015 Sep 30, 2015 10-K 2017-02-10
Q2 2015 $60.1M $10.1M -$7.17M -41.6% Apr 1, 2015 Jun 30, 2015 10-K 2017-02-10
Q1 2015 $67.3M $9.27M -$10M -52% Jan 1, 2015 Mar 31, 2015 10-K 2017-02-10
Q4 2014 $77.3M $20.8M +$123K +0.59% Oct 1, 2014 Dec 31, 2014 10-K 2016-02-12
Q3 2014 $77.2M $19.9M -$581K -2.84% Jul 1, 2014 Sep 30, 2014 10-K 2016-02-12
Q2 2014 $77.8M $17.2M -$2.42M -12.3% Apr 1, 2014 Jun 30, 2014 10-K 2016-02-12
Q1 2014 $80.2M $19.3M -$725K -3.62% Jan 1, 2014 Mar 31, 2014 10-K 2016-02-12
Q4 2013 $80.9M $20.7M +$2.32M +12.6% Oct 1, 2013 Dec 31, 2013 10-K 2015-02-17
Q3 2013 $78.6M $20.5M +$1.82M +9.74% Jul 1, 2013 Sep 30, 2013 10-K 2015-02-17
Q2 2013 $76.8M $19.7M +$2.67M +15.7% Apr 1, 2013 Jun 30, 2013 10-K 2015-02-17
Q1 2013 $74.1M $20M +$2.25M +12.7% Jan 1, 2013 Mar 31, 2013 10-K 2015-02-17
Q4 2012 $71.8M $18.4M +$1.02M +5.89% Oct 1, 2012 Dec 31, 2012 10-K 2014-02-13
Q3 2012 $70.8M $18.7M +$4.07M +27.9% Jul 1, 2012 Sep 30, 2012 10-K 2014-02-13
Q2 2012 $66.8M $17M +$2.29M +15.5% Apr 1, 2012 Jun 30, 2012 10-K 2014-02-13
Q1 2012 $64.5M $17.8M +$10.3M +137% Jan 1, 2012 Mar 31, 2012 10-K 2014-02-13
Q4 2011 $54.2M $17.4M +$700K +4.2% Oct 1, 2011 Dec 31, 2011 10-K 2013-02-19
Q3 2011 $53.5M $14.6M -$2.17M -12.9% Jul 1, 2011 Sep 30, 2011 10-K 2013-02-19
Q2 2011 $55.7M $14.7M -$534K -3.5% Apr 1, 2011 Jun 30, 2011 10-K 2013-02-19
Q1 2011 $56.2M $7.52M -$7.55M -50.1% Jan 1, 2011 Mar 31, 2011 10-K 2013-02-19
Q4 2010 $63.7M $16.7M Oct 1, 2010 Dec 31, 2010 10-K 2012-02-15
Q3 2010 $16.8M Jul 1, 2010 Sep 30, 2010 10-K 2012-02-15
Q2 2010 $15.2M Apr 1, 2010 Jun 30, 2010 10-K 2012-02-15
Q1 2010 $15.1M Jan 1, 2010 Mar 31, 2010 10-K 2012-02-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.